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Breast cancer is already by far the commonest cancer in 
women worldwide, with an estimated 1.4 million cases in 
2008 [1]. Th  e rates have been increasing steadily and 
there is every indication that they will continue to do so 
over the next few decades. Th   e greatest increases are in 
the developing world, where rates have traditionally been 
low, but with changing lifestyle they look destined to 
approach rates seen in western countries. In addition to 
this, the lifespan of women in the developing world is 
also increasing and so far more women are reaching an 
age where breast cancer rates are high. Th   us, the increase 
in breast cancer incidence, to a large extent, reﬂ  ects the 
major successes achieved in the developing world in 
combating infectious diseases and maternal deaths from 
childbirth.
Th   ere is little that can be done to deal with this success 
in preventing other diseases except to redirect more 
treatment and palliative resources to the problem, and to 
try to ﬁ  nd aﬀ  ordable and acceptable methods of provid-
ing screening programmes. However, there is some scope 
to try to hold in check the results of lifestyle changes, 
which are leading to the increase in age-speciﬁ  c breast 
cancer rates. Th  us, three broad approaches are possible 
within the screening and prevention arena: lifestyle 
changes to reduce or control increases in incidence rates; 
preventive therapy in high risk women; and breast 
screening.
Lifestyle
Much of the diﬀ   erence in breast cancer incidence 
between developed and developing countries can be 
explained by lifestyle diﬀ   erences. In particular, it has 
been estimated that diﬀ  erences in childbirth patterns and 
breast feeding can explain about a two-fold lower age-
speciﬁ   c incidence in the developing world, where a 
woman starts childbearing at a young age, has a large 
family and breast feeds each child for 1 to 2 years. 
Certainly there are enough other problems with large 
families to not recommend the maintenance of this 
practice, but continuing a high level of breast feeding 
oﬀ  ers one possible hope for containing the increase in 
breast cancer. It has been estimated from a large overview 
[2] that the relative risk of breast cancer is reduced by 
4.3% for every cumulative year of breast feeding, so 2 to 
3 years of lifetime breast feeding could reduce incidence 
by 10% or so. Another concern, which is important 
world  wide, are increases in obesity and reductions in 
physical activity. Much of the developing world has 
moved to a starchy, grain-based diet, which has led to 
several health issues, notably a skyrocketing of type 2 
diabetes. However, its impact on post-menopausal breast 
cancer has yet to be fully seen. Estimates suggest post-
menopausal breast cancer incidence increases by about 
1% per kilogram of adult weight [3], so that a 20 kg or 
greater diﬀ  erence would have an important impact at a 
population level. Weight gain in middle age appears to be 
important [4], so programmes aimed at both childhood 
and adult weight control would be valuable.
Physical exercise is also a protective factor, with even 
modest amounts of moderate to vigorous activity (2 to 
3 hours per week) having a 20 to 40% impact on incidence 
[5]. Control of alcohol consumption is also an issue, with 
an estimated relative risk increase of 7% for each drink 
consumed on a daily basis [6]. Th  is is also a worldwide 
issue.
Preventive therapy
Tamoxifen and raloxifene have both been shown to 
reduce the incidence of breast cancer by 30 to 40% and 
are licensed for prevention in some countries. However, 
they have signiﬁ  cant toxicity and use needs to be focused 
on high risk subgroups. Identiﬁ  cation of such subgroups 
is potentially diﬃ   cult in developing countries, and this 
strategy is best reserved for the developed world until 
procedures for identifying high risk women are more 
completely developed.
Screening
When practiced by well trained personnel, mammo-
graphic screening is eﬀ  ective at reducing mortality by 30 
to 40%, albeit at the expense of some overdiagnosis and 
treatment. However, the costs and infrastructure 
required make this infeasible for many parts of the  © 2010 BioMed Central Ltd
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© 2010 BioMed Central Ltddeveloping world (especially Africa), and only moderately 
resourced countries - for example, those in Eastern 
Europe - can seriously consider this now. At the other 
extreme, breast self-examination has proved to be 
ineﬀ   ective [7,8] and should not be recommended. A 
promising approach being explored in a large trial in 
Mumbai (n = 150,000) is clinical breast examination by 
trained doctors and nurses [9]. Th   is would appear feasible 
in low resource settings and the results of this trial are 
eagerly awaited.
Conclusion
Large increases in the number of breast cancer patients 
are certain to occur in the next few decades, partly as a 
result of the success in eradicating infectious diseases 
and maternal deaths, but also due to the ‘westernisation’ 
of lifestyle with its attendant increase in an individual 
risk, especially in the post-menopausal period. Control of 
certain lifestyle factors, notably maintaining breast 
feeding, avoiding obesity, alcohol consumption, and 
maintaining a high level of physical activity, may help to 
control this last factor.
Mammographic screening may be useful in some areas 
where adequate resources exist, but is currently not 
viable for much of the developing world, and the results 
of the trial on clinical breast examination are awaited as a 
further possible approach. Providing adequate treatment 
facilities and palliation should be the current priorities.
Competing interests
The author’s institute receives support from AstraZeneca to conduct a 
prevention trial with anastrozole and the author is on their advisory board.
Acknowledgements
This article has been published as part of Breast Cancer Research Volume 12 
Supplement 4, 2010: Controversies in Breast Cancer 2010. The full contents 
of the supplement are available online at http://breast-cancer-research.com/
supplements/12/S4
Published: 20 December 2010
References
1.  Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of 
worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 
[Epub ahead of print].
2.  Collaborative Group on Hormonal Factors and Breast Cancer: Breast cancer 
and breastfeeding: collaborative reanalysis of individual data from 47 
epidemiological studies in 30 countries, including 50302 women with 
breast cancer and 96973 women without the disease. Lancet 2002, 
360:187-195.
3.  Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M: Body-mass index and 
incidence of cancer: a systematic review and meta-analysis of prospective 
observational studies. Lancet 2008, 371:569-578.
4.  Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE, Folsom AR, 
Sellers TA: Association of gain and loss of weight before and after 
menopause with risk of postmenopausal breast cancer in the Iowa 
women’s health study. Cancer Epidemiol Biomarkers Prev 2005, 14:656-661.
5.  Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, Berlin JA, 
Daling JR, McDonald JA, Norman SA, Malone KE, Strom BL, Liff   J, Folger SG, 
Simon MS, Burkman RT, Marchbanks PA, Weiss LK, Spirtas R: Lifetime 
recreational exercise activity and breast cancer risk among black women 
and white women. J Natl Cancer Inst 2005, 97:1671-1679.
6.  Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, Coates RJ, Liff   
JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, 
Schuman L, Stewart W, Szklo M, Bain C, Schofi  eld F, Siskind V, Band P, 
Coldman AJ, Gallagher RP, Hislop TG, Yang P, Kolonel LM, Nomura AM, Hu J, 
Johnson KC, Mao Y, De Sanjosé S, et al.: Alcohol, tobacco and breast cancer 
- collaborative reanalysis of individual data from 53 epidemiological 
studies, including 58,515 women with breast cancer and 95,067 women 
without the disease. Br J Cancer 2002, 87:1234-1245.
7.  Semiglazov VF, Sagaidak VN, Moiseyenko VM, Mikhailov EA: Study of the role 
of breast self-examination in the reduction of mortality from breast 
cancer. The Russian Federation/World Health Organization Study. Eur J 
Cancer 1993, 29A:2039-2046.
8.  Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, 
Zhao GL, Pan LD, Li W, Wu C, Coriaty Z, Evans I, Lin MG, Stalsberg H, Self SG: 
Randomized trial of breast self-examination in Shanghai: fi  nal results. J 
Natl Cancer Inst 2002, 94:1445-1457.
9.  Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R, Miller AB, Daniel EE, 
Gupta S, Uplap P, Thakur MH, Ramani S, Kerkar R, Ganesh B, Shastri SS: 
A cluster randomized, controlled trial of breast and cervix cancer 
screening in Mumbai, India: methodology and interim results after three 
rounds of screening. Int J Cancer 2010, 126:976-984.
doi:10.1186/bcr2738
Cite this article as: Cuzick J: Breast cancer prevention in the developing 
world. Breast Cancer Research 2010, 12(Suppl 4):S9.
Cuzick Breast Cancer Research 2010, 12(Suppl 4):S9
http://breast-cancer-research.com/supplements/12/S4/S9
Page 2 of 2